|
Secondary prevention
Citations 411-420 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Clinical Cardiology: New Frontiers
Principles From Clinical Trials Relevant to Clinical Practice: Part II
- Robert M. Califf and David L. DeMets
Circulation 2002;106:1172-1175, doi:10.1161/01.CIR.0000023218.39412.32
[Full text]
- Articles
Simvastatin Lowers C-Reactive Protein Within 14 Days. An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction
- Julie K. Plenge, Teri L. Hernandez, Kathleen M. Weil, Paul Poirier, Gary K. Grunwald, Santica M. Marcovina, and Robert H. Eckel
Circulation published August 26, 2002, doi:10.1161/01.CIR.0000029743.68247.31
[Abstract]
- Clinical Cardiology: New Frontiers
Principles From Clinical Trials Relevant to Clinical Practice: Part I
- Robert M. Califf and David L. DeMets
Circulation 2002;106:1015-1021, doi:10.1161/01.CIR.0000023260.78078.BB
[Full text]
- Correspondence
Primary Prevention Lipid-Lowering Drug Therapy Response
- Donald O. Fedder, Carol E. Koro, Gilbert J. LItalien, Antonio M. Gotto, Jr, and Lewis H. Kuller
Circulation 2002;106:e35-36e, doi:10.1161/01.CIR.0000025828.88749.55
[Full text]
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
- David L. DeMets and Robert M. Califf
Circulation 2002;106:880-886, doi:10.1161/01.CIR.0000023220.26465.89
[Full text]
- Clinical Investigations and Reports
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation
- Terence Kavanagh, Donald J. Mertens, Larry F. Hamm, Joseph Beyene, Johanna Kennedy, Paul Corey, and Roy J. Shephard
Circulation 2002;106:666-671; published online before print as doi:10.1161/01.CIR.0000024413.15949.ED
[Abstract]
[Full text]
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part I
- David L. DeMets and Robert M. Califf
Circulation 2002;106:746-751, doi:10.1161/01.CIR.0000023219.51483.66
[Full text]
- Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part II
- Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:626-630, doi:10.1161/01.CIR.0000021408.40925.63
[Full text]
- Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I
- Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:516-520, doi:10.1161/01.CIR.0000021407.93752.7B
[Full text]
- Clinical Investigations and Reports
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation
- Terence Kavanagh, Donald J. Mertens, Larry F. Hamm, Joseph Beyene, Johanna Kennedy, Paul Corey, and Roy J. Shephard
Circulation published July 22, 2002, doi:10.1161/01.CIR.0000024413.15949.ED
[Abstract]
|
|